ES2067744T3 - Aminas heterociclicas con actividad sobre el sistema nervioso central. - Google Patents

Aminas heterociclicas con actividad sobre el sistema nervioso central.

Info

Publication number
ES2067744T3
ES2067744T3 ES90908816T ES90908816T ES2067744T3 ES 2067744 T3 ES2067744 T3 ES 2067744T3 ES 90908816 T ES90908816 T ES 90908816T ES 90908816 T ES90908816 T ES 90908816T ES 2067744 T3 ES2067744 T3 ES 2067744T3
Authority
ES
Spain
Prior art keywords
sub
alkyl
activity
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90908816T
Other languages
English (en)
Inventor
Malcolm W Moon
Richard F Heier
Jeanette K Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2067744T3 publication Critical patent/ES2067744T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPUESTOS CONTENIENDO NITROGENO TRICICLICO, CON ACTIVIDAD EN EL SISTEMA NERVIOSO CENTRAL DE FORMULA ESTRUCTURAL (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, DONDE R SUB 1, R SUB 2 Y R SUB 3 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO C SUB 1-6, ALQUENILO O ALQUINILO, CICLOALQUILO C SUB 3-10, O R SUB 1 Y R SUB 2 SE UNEN PARA FORMAR UNA AMINA CICLICA C SUB 3-7 QUE PUEDE CONTENER HETEROATOMOS ADICIONALES; X ES HIDROGENO, ALQUILO C SUB 1-6, HALOGENO, HIDROXI, ALCOXI, CIANO, CARBOXAMIDA, CARBOXILO, O CARBOALCOXILO; A ES SO SUB 2, N, CH, CH SUB 2, CHCH SUB 3, C = O, C = S, C-SCH SUB 3, C = NH, C-NH SUB 2, C-NHCH SUB 3, C-NHCOOCH SUB 3, O C-NHCN; B ES CH SUB 2, CH, C = O, N, NH O N-CH SUB 3; N ES 0 O 1; Y D ES CH, CH SUB 2, C = O, O, N, NH O N-CH SUB 3. ESTOS NUEVOS COMPUESTOS SON APROPIADOS PARA TRATAR LA ESQUIZOFRENIA, ENFERMEDAD DE PARKINSON, ANSIEDAD, DEPRESION O COMO COMPUESTOS PARA BAJAR LA PRESION SANGUINEA EN ANIMALES O RECEPTORES HUMANOS.
ES90908816T 1989-06-09 1990-05-15 Aminas heterociclicas con actividad sobre el sistema nervioso central. Expired - Lifetime ES2067744T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36437489A 1989-06-09 1989-06-09

Publications (1)

Publication Number Publication Date
ES2067744T3 true ES2067744T3 (es) 1995-04-01

Family

ID=23434241

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90908816T Expired - Lifetime ES2067744T3 (es) 1989-06-09 1990-05-15 Aminas heterociclicas con actividad sobre el sistema nervioso central.

Country Status (15)

Country Link
EP (1) EP0480939B1 (es)
JP (1) JP2955358B2 (es)
KR (1) KR0167346B1 (es)
AT (1) ATE117688T1 (es)
AU (1) AU626427B2 (es)
CA (1) CA2051697C (es)
DE (1) DE69016430T2 (es)
DK (1) DK0480939T3 (es)
ES (1) ES2067744T3 (es)
FI (2) FI96310C (es)
HK (1) HK65397A (es)
HU (2) HU210264B (es)
NO (1) NO301421B1 (es)
RU (1) RU2023712C1 (es)
WO (1) WO1990015058A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
TW260660B (es) * 1993-04-22 1995-10-21 Sumitomo Pharma
DE4314593A1 (de) * 1993-04-28 1994-11-03 Schering Ag Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln
CA2166700C (en) * 1993-07-27 2000-04-18 Arthur G. Romero Heterocyclic amines having central nervous system activity
FR2719843B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique.
EP0705834A1 (de) * 1994-07-27 1996-04-10 Ciba-Geigy Ag Azaaliphatisch Überbrückte Chinoxalin-2,3-dione
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
IL122944A (en) * 1995-08-10 2001-11-25 Bayer Ag Halogenobenzimidazoles, their preparation and microbicidal compositions containing them
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6197339B1 (en) * 1997-09-30 2001-03-06 Pharmacia & Upjohn Company Sustained release tablet formulation to treat Parkinson's disease
US6455564B1 (en) * 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
AU767089B2 (en) 1999-02-05 2003-10-30 Pharmacia & Upjohn Company Process to prepare (5R)-(methylamino)-5,6-dihydro-4H- imidazo(4,5,1-ij)-quinolin-2(1H)-one
US7074927B2 (en) 1999-05-13 2006-07-11 Pharmacia & Upjohn Company Heterocyclic amines having central nervous system activity
DE19954707A1 (de) 1999-11-13 2001-05-17 Merck Patent Gmbh Imidazolverbindungen als Phosphodiesterase VII-Hemmer
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
CN1450898A (zh) 2000-04-21 2003-10-22 法玛西雅厄普约翰美国公司 用于治疗纤维肌痛和慢性疲劳综合症的化合物
AR033520A1 (es) * 2000-04-27 2003-12-26 Upjohn Co (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona
AU2001283393B2 (en) 2000-08-16 2005-09-22 Pharmacia & Upjohn Company Compounds for the treatment of addictive disorders
AR031199A1 (es) 2000-11-03 2003-09-10 Wyeth Corp Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados
US6759405B2 (en) 2000-11-03 2004-07-06 Wyeth Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
AR031202A1 (es) 2000-11-03 2003-09-10 Wyeth Corp Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados
DE60216457T2 (de) * 2001-02-27 2007-09-20 Ortho-Mcneil Pharmaceutical, Inc. Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
TW200307682A (en) * 2002-04-25 2003-12-16 Wyeth Corp 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
TW200307540A (en) 2002-04-25 2003-12-16 Wyeth Corp [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
TWI312781B (en) * 2002-04-25 2009-08-01 [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
US20050079217A1 (en) * 2002-07-25 2005-04-14 Ganorkar Loksidh D. Sustained-release tablet composition comprising a dopamine receptor agonist
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
AR040680A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Composicion de tabletas de liberacion sostenida
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
EP1569649A2 (en) * 2002-10-25 2005-09-07 Pharmacia & Upjohn Company LLC Use of heterocyclic amine-type compounds as neuroprotective agents
US7262297B2 (en) * 2003-05-15 2007-08-28 Hoffmann-La Roche Inc. Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
CA2533824A1 (en) * 2003-07-31 2005-02-10 Irm, Llc Bicyclic compounds and compositions as pdf inhibitors
US20050250803A1 (en) * 2003-11-26 2005-11-10 Pfizer Inc Combination of dopamine agonists and monoamine reuptake inhibitors
NZ553587A (en) 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmacutically acceptable salt thereof
EA201001086A1 (ru) 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
GT200500317A (es) 2004-11-05 2006-10-27 Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
TW200635926A (en) * 2004-11-05 2006-10-16 Wyeth Corp Metabolites of ceratin [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
MX2007016185A (es) 2005-06-14 2008-03-07 Schering Corp Inhibidores de aspartil proteasa heterociclicos macrociclicos.
AR054849A1 (es) 2005-07-26 2007-07-18 Wyeth Corp Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
US20140080813A1 (en) 2012-09-14 2014-03-20 AbbVie Deutschland GmbH & Co. KG Tricyclic quinoline and quinoxaline derivatives
KR20150056608A (ko) 2012-09-14 2015-05-26 아비에 도이치란트 게엠베하 운트 콤파니 카게 트리사이클릭 퀴놀린 및 퀴녹살린 유도체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701260A (ko) * 1988-05-09 1990-12-01 로버트 에이. 아미테이지 2,3-디하이드로-1h-페날렌-2-아민 불안해소/우울증 방지제

Also Published As

Publication number Publication date
AU5743890A (en) 1991-01-07
CA2051697A1 (en) 1990-12-10
HU905216D0 (en) 1992-02-28
JP2955358B2 (ja) 1999-10-04
CA2051697C (en) 1996-10-08
HU210264B (en) 1995-03-28
EP0480939A1 (en) 1992-04-22
KR0167346B1 (ko) 1999-01-15
NO914827L (no) 1992-02-07
AU626427B2 (en) 1992-07-30
RU2023712C1 (ru) 1994-11-30
NO914827D0 (no) 1991-12-06
FI944704L (fi) 1994-10-07
FI96310C (fi) 1996-06-10
FI915715A0 (fi) 1991-12-04
FI96687B (fi) 1996-04-30
WO1990015058A1 (en) 1990-12-13
FI96687C (fi) 1996-08-12
FI944704A0 (fi) 1994-10-07
EP0480939B1 (en) 1995-01-25
JPH04506071A (ja) 1992-10-22
ATE117688T1 (de) 1995-02-15
HUT60269A (en) 1992-08-28
DE69016430D1 (de) 1995-03-09
FI96310B (fi) 1996-02-29
DE69016430T2 (de) 1995-06-01
HU211702A9 (en) 1995-12-28
HK65397A (en) 1997-05-23
DK0480939T3 (da) 1995-07-10
KR920701204A (ko) 1992-08-11
NO301421B1 (no) 1997-10-27

Similar Documents

Publication Publication Date Title
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
AR030507A1 (es) Compuesto de pirazolopiridina y los usos farmaceuticos del mismo
ES2111650T3 (es) Derivados aciclicos de etilenodiamina como antagonistas de receptores de la sustancia p.
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
ES2051867T3 (es) Procedimiento de preparacion de un compuesto heterociclico.
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
CL2003002050A1 (es) Compuestos derivados de 1-piperazin-1,2-dihidroindeno, su composicion farmaceutica y el uso de esta para tratar enfermedades del sistema nervioso central.
PE20030759A1 (es) Uso de ureas de benzotiazoles
ES2181742T3 (es) Derivados de benzoimidazol, su produccion y uso como antagonistas de angiotensina ii.
PT89110A (pt) Processo de preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
ES2062009T4 (es) Agentes antifungicos derivados de triazol
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
ES2163071T3 (es) Sulfonamidas y su utilizacion.
ES2135414T3 (es) Antagonistas del receptor 5-ht4.
ES2157224T3 (es) Derivados de 5-arilindol y su uso como agonistas de serotonina (5-ht 1).
PT628311E (pt) Derivado de xantina com actividade antidepressiva
DK0480939T3 (da) Heterocycliske aminer med virkning på centralnervesystemet
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
PE20030867A1 (es) Derivados de quinazolinona
AR028475A1 (es) Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
WO1996005166A1 (en) Substituted amine derivative and medicinal composition containing the same
ES2158861T3 (es) 4-imidometil-1-(2'-fenil-2'-oxoetil)-piperidinas como inhibidores de los receptores 5ht2 de la serotonina, su preparacion y sus aplicaciones terapeuticas.
AR027578A1 (es) Derivados de indano

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 480939

Country of ref document: ES